Events
This calendar is offered as a resource to help you find opportunities and learning environments that may interest you. You will be able to speak to a Tandem representative and learn more about our products at all of the events featured here.*
Tandem's Predictive Technologies: Pediatric Pivotal Trial of Control-IQ Technology in Children with Type 1 Diabetes
Join Betsy Dokken, NP, PhD, Director of Clinical Affairs at Tandem Diabetes Care, to learn more about the results from the pediatric pivotal trial (DCLP5) data published in the New England Journal of Medicine (NEJM): A Randomized Control of Closed-Loop Control in Children with Type 1 Diabetes. This webinar will cover the study results of the pivotal trial and a pediatric case study. The presentation will be followed by a speaker Q&A.
Originally broadcast on February 16, 2021, Betsy Dokken, NP, PhD, Director of Clinical Affairs at Tandem Diabetes Care, presented the results from the pediatric pivotal trial (DCLP5) data published in the New England Journal of Medicine (NEJM): A Randomized Control of Closed-Loop Control in Children with Type 1 Diabetes.
This webinar covered the study results of the pivotal trial and a pediatric case study. The presentation was followed by a speaker Q&A.
Tandem's Predictive Technologies: Pediatric Pivotal Trial of Control-IQ Technology in Children with Type 1 Diabetes
Join Betsy Dokken, NP, PhD, Director of Clinical Affairs at Tandem Diabetes Care, to learn more about the results from the pediatric pivotal trial (DCLP5) data published in the New England Journal of Medicine (NEJM): A Randomized Control of Closed-Loop Control in Children with Type 1 Diabetes. This webinar will cover the study results of the pivotal trial and a pediatric case study. The presentation will be followed by a speaker Q&A.
Originally broadcast on February 16, 2021, Betsy Dokken, NP, PhD, Director of Clinical Affairs at Tandem Diabetes Care, presented the results from the pediatric pivotal trial (DCLP5) data published in the New England Journal of Medicine (NEJM): A Randomized Control of Closed-Loop Control in Children with Type 1 Diabetes.
This webinar covered the study results of the pivotal trial and a pediatric case study. The presentation was followed by a speaker Q&A.
* Tandem Diabetes Care will have an exhibit table at each event, but Tandem is not the event organizer and does not have control of the information shared outside of its exhibit space.
Leave a commentOrder by
Newest on top Oldest on top